Eye care specialist Allergan has selected Aptar Pharma’s patient-friendly Ophthalmic Squeeze Dispenser for its new dry eye product, Restasis Multidose. Designed to handle prescription eye treatment formulations without ...
Tags: Allergan, Dry Eye Product
Posted in Medical Device Business by Chris Newmarker on April 3, 2015 Robert Cascella was previously CEO of Hologic. He joins Philips as the Dutch multinational increasingly focuses on what it calls HealthTech. Robert Cascella, who ...
Tags: Philips, LED components, Medicine
Posted in Medical Device Business by Nancy Crotti on December 15, 2014 Just when you thought they couldn’t get more widespread or expensive, the medical device mergers-and-acquisitions of 2014 continue to astound. Allergan ...
Tags: DNA sequencing market, lab products, Health
Posted in Medical Device Business by Chris Newmarker on December 11, 2014 2014 has turned out to be a pretty decent year for the world’s 40 largest medical device companies: Only six of them have seen their stock prices decline, and ...
Tags: Medical Device, Health
Posted in Medical Device Business by Brian Buntz on November 18, 2014 Irvine, CA–based Allergan has been adamant in fighting off a hostile takeover attempt from Valeant Pharmaceuticals International for the past seven months. But ...
Tags: silicone breast, Botox, Health
The medtech jobs picture looked rosy in 2013, with the top 15 device makers in hiring mode, according to an EP Vantage report out this week. Excluding pharmaceutical spinoffs, these companies expanded their collective workforce by 6%, the ...
Tags: Medtech Jobs, Health, Medicine
The U.S. Food and Drug Administration is announcing the initiation of the Secure Supply Chain Pilot Program to enhance the security of imported drugs. In August 2013, the FDA published a notice in the Federal Register (78 FR 51192) to ...
Allergan has received a positive opinion for its Vistabel (botulinum toxin type A) from France's National Security Agency of Medicines and Health Products (ANSM) to treat moderate to severe crow's feet lines in adult patients. The ...
Tags: Allergan, Crow's Feet Lines
Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan (AGN), to develop new medicines for ophthalmic diseases. The deal will see the ...
Tags: injectable drug, Innocore
US-based biopharmaceutical company Acadia Pharmaceuticals's glaucoma collaboration partner Allergan has advanced a new additional drug candidate into preclinical development for the treatment of glaucoma. Acadia CEO Uli Hacksell said that ...
Tags: Preclinical Development, Allergan
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Allergan's New Drug Application (NDA) for Levadex (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults. In addition ...
Tags: Migraine Therapy, Medicine
Applying big data approaches to information security can help enterprises build better situational awareness capabilities, but implementation could prove to be a major challenge, security experts said at the RSA Conference 2013 being held ...
Tags: information security, RSA Conference 2013, data aggregation
The USFDA has approved Allergan's Botox (onabotulinumtoxinA) as overactive bladder (OAB) therapy for adults who do not respond to or who cannot tolerate an anticholinergic medication. The approval was based on safety and efficacy data ...
Tags: FDA, Allergan overactive bladder, anticholinergic treatments
American Medical Systems (AMS), an Endo Health Solutions company, and Allergan have entered into an agreement to jointly develop and seek regulatory approval for the delivery of Botox (onabotulinumtoxinA) using the JetTouch system. ...
Tags: AMS, JetTouch system, medical application
Pathwork Diagnostics, a developer of oncology diagnostics assays, has named Lee McCracken as the company's new chief executive officer (CEO). Pathwork Diagnostics board chairman Peter Klemm said,"Lee, with his considerable leadership and ...
Tags: Pathwork Diagnostics, Lee McCracken, CEO